Improved Determination of Drug Metabolism by Perifusion of Recombinant V79 Cells Carrying Human CYP3A4

Recombinant V79Mz cell lines stably co-expressing human CYP3A4 and human NADPH-cytochrome P450 oxidoreductase were used to compare testosterone metabolism under conventional stationary cultivation and under perifusion. In contrast to stationary culture, steady-state conditions for the production of...

Full description

Saved in:
Bibliographic Details
Published in:Toxicology in vitro 1999-08, Vol.13 (4), p.639-643
Main Authors: Gebhardt, R, Lippert, C, Schneider, A, Doehmer, J
Format: Article
Language:English
Subjects:
Biological and medical sciences
cytochrome P450
cytochrome P4503A4
drug metabolism
General pharmacology
Medical sciences
perifusion
Pharmacokinetics. Pharmacogenetics. Drug-receptor interactions
Pharmacology. Drug treatments
recombinant cell lines
testosterone
V79 cells
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
cited_by cdi_FETCH-LOGICAL-c422t-b667ac8d86bbd958ef5959005d0864d7b800c2623ab91b111e17c597163049e53
cites cdi_FETCH-LOGICAL-c422t-b667ac8d86bbd958ef5959005d0864d7b800c2623ab91b111e17c597163049e53
container_end_page 643
container_issue 4
container_start_page 639
container_title Toxicology in vitro
container_volume 13
creator Gebhardt, R
Lippert, C
Schneider, A
Doehmer, J
description Recombinant V79Mz cell lines stably co-expressing human CYP3A4 and human NADPH-cytochrome P450 oxidoreductase were used to compare testosterone metabolism under conventional stationary cultivation and under perifusion. In contrast to stationary culture, steady-state conditions for the production of 6 β-hydoxytestosterone were established in the perifusion system even when different concentrations of testosterone were infused sequentially. As a consequence of these favourable conditions, threefold higher maximal metabolic rates could be measured and kinetic constants could be determined more reproducibly than in stationary culture. The results indicate that CYP3A4 shows an autocatalytic reaction kinetic probably due to two binding sites for testosterone.
doi_str_mv 10.1016/S0887-2333(99)00020-X
format article
fullrecord <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_734014072</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><els_id>S088723339900020X</els_id><sourcerecordid>734014072</sourcerecordid><originalsourceid>FETCH-LOGICAL-c422t-b667ac8d86bbd958ef5959005d0864d7b800c2623ab91b111e17c597163049e53</originalsourceid><addsrcrecordid>eNqFkUlvFDEQhS0EIkPCTwD5gFgODV7b9imKOkAiBSViUzhZtrs6Muol2N2R5t_jyUySG5zq8r2qV-8h9IKS95TQ-sM3orWqGOf8rTHvCCGMVJeP0IpqZSpOlXqMVvfIHnqW8-8CSc3IU7THSC2FZHqFutPhOk030OJjmCENcXRznEY8dfg4LVf4C8zOT33MA_ZrfAEpdkveAV8hTIMvinHGP5XBDfR9xo1LaR3HK3yyDG7Eza8LfiQO0JPO9Rme7-Y--vHp4_fmpDo7_3zaHJ1VQTA2V76ulQu61bX3rZEaOmmkKbZbomvRKq8JCaxm3HlDPaUUqArSKFpzIgxIvo_ebPeWp_4skGc7xByKLzfCtGSruCBUEMUK-fqfJFWCC8lFAeUWDGnKOUFnr1McXFpbSuymCntbhd3kbI2xt1XYy6J7uTuw-AHae9Vd9gV4tQNcDq7vkhtDzA_bjeBab1463GJQcruJkGwOEcYAbUwQZttO8T9O_gJiBqOC</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>17434534</pqid></control><display><type>article</type><title>Improved Determination of Drug Metabolism by Perifusion of Recombinant V79 Cells Carrying Human CYP3A4</title><source>Elsevier</source><creator>Gebhardt, R ; Lippert, C ; Schneider, A ; Doehmer, J</creator><contributor>Blaauboer, BJ ; Marano, F ; van der Valk, J (eds)</contributor><creatorcontrib>Gebhardt, R ; Lippert, C ; Schneider, A ; Doehmer, J ; Blaauboer, BJ ; Marano, F ; van der Valk, J (eds)</creatorcontrib><description>Recombinant V79Mz cell lines stably co-expressing human CYP3A4 and human NADPH-cytochrome P450 oxidoreductase were used to compare testosterone metabolism under conventional stationary cultivation and under perifusion. In contrast to stationary culture, steady-state conditions for the production of 6 β-hydoxytestosterone were established in the perifusion system even when different concentrations of testosterone were infused sequentially. As a consequence of these favourable conditions, threefold higher maximal metabolic rates could be measured and kinetic constants could be determined more reproducibly than in stationary culture. The results indicate that CYP3A4 shows an autocatalytic reaction kinetic probably due to two binding sites for testosterone.</description><identifier>ISSN: 0887-2333</identifier><identifier>EISSN: 1879-3177</identifier><identifier>DOI: 10.1016/S0887-2333(99)00020-X</identifier><identifier>PMID: 20654528</identifier><identifier>CODEN: TIVIEQ</identifier><language>eng</language><publisher>Oxford: Elsevier Ltd</publisher><subject>Biological and medical sciences ; cytochrome P450 ; cytochrome P4503A4 ; drug metabolism ; General pharmacology ; Medical sciences ; perifusion ; Pharmacokinetics. Pharmacogenetics. Drug-receptor interactions ; Pharmacology. Drug treatments ; recombinant cell lines ; testosterone ; V79 cells</subject><ispartof>Toxicology in vitro, 1999-08, Vol.13 (4), p.639-643</ispartof><rights>1999 Elsevier Science Ltd</rights><rights>1999 INIST-CNRS</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c422t-b667ac8d86bbd958ef5959005d0864d7b800c2623ab91b111e17c597163049e53</citedby><cites>FETCH-LOGICAL-c422t-b667ac8d86bbd958ef5959005d0864d7b800c2623ab91b111e17c597163049e53</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>309,310,314,780,784,789,790,23930,23931,25140,27924,27925</link.rule.ids><backlink>$$Uhttp://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&amp;idt=1943885$$DView record in Pascal Francis$$Hfree_for_read</backlink><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/20654528$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><contributor>Blaauboer, BJ</contributor><contributor>Marano, F</contributor><contributor>van der Valk, J (eds)</contributor><creatorcontrib>Gebhardt, R</creatorcontrib><creatorcontrib>Lippert, C</creatorcontrib><creatorcontrib>Schneider, A</creatorcontrib><creatorcontrib>Doehmer, J</creatorcontrib><title>Improved Determination of Drug Metabolism by Perifusion of Recombinant V79 Cells Carrying Human CYP3A4</title><title>Toxicology in vitro</title><addtitle>Toxicol In Vitro</addtitle><description>Recombinant V79Mz cell lines stably co-expressing human CYP3A4 and human NADPH-cytochrome P450 oxidoreductase were used to compare testosterone metabolism under conventional stationary cultivation and under perifusion. In contrast to stationary culture, steady-state conditions for the production of 6 β-hydoxytestosterone were established in the perifusion system even when different concentrations of testosterone were infused sequentially. As a consequence of these favourable conditions, threefold higher maximal metabolic rates could be measured and kinetic constants could be determined more reproducibly than in stationary culture. The results indicate that CYP3A4 shows an autocatalytic reaction kinetic probably due to two binding sites for testosterone.</description><subject>Biological and medical sciences</subject><subject>cytochrome P450</subject><subject>cytochrome P4503A4</subject><subject>drug metabolism</subject><subject>General pharmacology</subject><subject>Medical sciences</subject><subject>perifusion</subject><subject>Pharmacokinetics. Pharmacogenetics. Drug-receptor interactions</subject><subject>Pharmacology. Drug treatments</subject><subject>recombinant cell lines</subject><subject>testosterone</subject><subject>V79 cells</subject><issn>0887-2333</issn><issn>1879-3177</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>1999</creationdate><recordtype>article</recordtype><recordid>eNqFkUlvFDEQhS0EIkPCTwD5gFgODV7b9imKOkAiBSViUzhZtrs6Muol2N2R5t_jyUySG5zq8r2qV-8h9IKS95TQ-sM3orWqGOf8rTHvCCGMVJeP0IpqZSpOlXqMVvfIHnqW8-8CSc3IU7THSC2FZHqFutPhOk030OJjmCENcXRznEY8dfg4LVf4C8zOT33MA_ZrfAEpdkveAV8hTIMvinHGP5XBDfR9xo1LaR3HK3yyDG7Eza8LfiQO0JPO9Rme7-Y--vHp4_fmpDo7_3zaHJ1VQTA2V76ulQu61bX3rZEaOmmkKbZbomvRKq8JCaxm3HlDPaUUqArSKFpzIgxIvo_ebPeWp_4skGc7xByKLzfCtGSruCBUEMUK-fqfJFWCC8lFAeUWDGnKOUFnr1McXFpbSuymCntbhd3kbI2xt1XYy6J7uTuw-AHae9Vd9gV4tQNcDq7vkhtDzA_bjeBab1463GJQcruJkGwOEcYAbUwQZttO8T9O_gJiBqOC</recordid><startdate>19990801</startdate><enddate>19990801</enddate><creator>Gebhardt, R</creator><creator>Lippert, C</creator><creator>Schneider, A</creator><creator>Doehmer, J</creator><general>Elsevier Ltd</general><general>Elsevier Science</general><scope>IQODW</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7U7</scope><scope>C1K</scope><scope>7X8</scope></search><sort><creationdate>19990801</creationdate><title>Improved Determination of Drug Metabolism by Perifusion of Recombinant V79 Cells Carrying Human CYP3A4</title><author>Gebhardt, R ; Lippert, C ; Schneider, A ; Doehmer, J</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c422t-b667ac8d86bbd958ef5959005d0864d7b800c2623ab91b111e17c597163049e53</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>1999</creationdate><topic>Biological and medical sciences</topic><topic>cytochrome P450</topic><topic>cytochrome P4503A4</topic><topic>drug metabolism</topic><topic>General pharmacology</topic><topic>Medical sciences</topic><topic>perifusion</topic><topic>Pharmacokinetics. Pharmacogenetics. Drug-receptor interactions</topic><topic>Pharmacology. Drug treatments</topic><topic>recombinant cell lines</topic><topic>testosterone</topic><topic>V79 cells</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Gebhardt, R</creatorcontrib><creatorcontrib>Lippert, C</creatorcontrib><creatorcontrib>Schneider, A</creatorcontrib><creatorcontrib>Doehmer, J</creatorcontrib><collection>Pascal-Francis</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>Toxicology Abstracts</collection><collection>Environmental Sciences and Pollution Management</collection><collection>MEDLINE - Academic</collection><jtitle>Toxicology in vitro</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Gebhardt, R</au><au>Lippert, C</au><au>Schneider, A</au><au>Doehmer, J</au><au>Blaauboer, BJ</au><au>Marano, F</au><au>van der Valk, J (eds)</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Improved Determination of Drug Metabolism by Perifusion of Recombinant V79 Cells Carrying Human CYP3A4</atitle><jtitle>Toxicology in vitro</jtitle><addtitle>Toxicol In Vitro</addtitle><date>1999-08-01</date><risdate>1999</risdate><volume>13</volume><issue>4</issue><spage>639</spage><epage>643</epage><pages>639-643</pages><issn>0887-2333</issn><eissn>1879-3177</eissn><coden>TIVIEQ</coden><abstract>Recombinant V79Mz cell lines stably co-expressing human CYP3A4 and human NADPH-cytochrome P450 oxidoreductase were used to compare testosterone metabolism under conventional stationary cultivation and under perifusion. In contrast to stationary culture, steady-state conditions for the production of 6 β-hydoxytestosterone were established in the perifusion system even when different concentrations of testosterone were infused sequentially. As a consequence of these favourable conditions, threefold higher maximal metabolic rates could be measured and kinetic constants could be determined more reproducibly than in stationary culture. The results indicate that CYP3A4 shows an autocatalytic reaction kinetic probably due to two binding sites for testosterone.</abstract><cop>Oxford</cop><pub>Elsevier Ltd</pub><pmid>20654528</pmid><doi>10.1016/S0887-2333(99)00020-X</doi><tpages>5</tpages></addata></record>
fulltext fulltext
identifier ISSN: 0887-2333
ispartof Toxicology in vitro, 1999-08, Vol.13 (4), p.639-643
issn 0887-2333
1879-3177
language eng
recordid cdi_proquest_miscellaneous_734014072
source Elsevier
subjects Biological and medical sciences
cytochrome P450
cytochrome P4503A4
drug metabolism
General pharmacology
Medical sciences
perifusion
Pharmacokinetics. Pharmacogenetics. Drug-receptor interactions
Pharmacology. Drug treatments
recombinant cell lines
testosterone
V79 cells
title Improved Determination of Drug Metabolism by Perifusion of Recombinant V79 Cells Carrying Human CYP3A4
url http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-06T05%3A53%3A10IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Improved%20Determination%20of%20Drug%20Metabolism%20by%20Perifusion%20of%20Recombinant%20V79%20Cells%20Carrying%20Human%20CYP3A4&rft.jtitle=Toxicology%20in%20vitro&rft.au=Gebhardt,%20R&rft.date=1999-08-01&rft.volume=13&rft.issue=4&rft.spage=639&rft.epage=643&rft.pages=639-643&rft.issn=0887-2333&rft.eissn=1879-3177&rft.coden=TIVIEQ&rft_id=info:doi/10.1016/S0887-2333(99)00020-X&rft_dat=%3Cproquest_cross%3E734014072%3C/proquest_cross%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-c422t-b667ac8d86bbd958ef5959005d0864d7b800c2623ab91b111e17c597163049e53%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_pqid=17434534&rft_id=info:pmid/20654528&rfr_iscdi=true